Gamma-aminobutyric acid type A receptor alpha-2 beta-2 gamma-2 subtype (GABAA receptor α2β2γ2)

The Gamma-aminobutyric acid type A (GABAA) receptor alpha-2 beta-2 gamma-2 subtype is a heteropentameric ligand-gated ion channel that mediates fast inhibitory neurotransmission in the central nervous system [1, 2]. It is composed of two alpha-2, two beta-2, and one gamma-2 subunit arranged around a central chloride-selective pore [1, 4]. Upon binding of the endogenous neurotransmitter GABA, the channel opens to allow chloride ion influx, resulting in membrane hyperpolarization and reduced neuronal excitability [2, 10]. This specific subtype is prominently expressed in brain regions associated with emotional processing, such as the amygdala and hippocampus, as well as in the spinal cord [5, 6]. It plays a critical role in the regulation of anxiety and the processing of nociceptive signals, making it a primary target for anxiolytic and analgesic drug development [5, 6]. Pharmacologically, the receptor is modulated by various classes of drugs, most notably benzodiazepines, which act as positive allosteric modulators at the alpha/gamma subunit interface [3, 4]. Other modulators include barbiturates, neurosteroids, and general anesthetics like propofol and etomidate, which enhance chloride conductance [1, 3]. Dysfunction of this receptor subtype is linked to several neuropsychiatric conditions, including alcohol use disorder, epilepsy, and schizophrenia [5, 7]. Selective targeting of the alpha-2 subunit is a major research focus aimed at producing anxiolytic effects without the sedation and cognitive impairment associated with alpha-1-containing receptors [5].

Other names

GABA(A) receptor alpha2beta2gamma2GABRA2/GABRB2/GABRG2 complexAlpha2-containing GABAA receptorα2β2γ2 GABAA receptorGABA-A receptor alpha-2/beta-2/gamma-2

Positive allosteric modulation (PAM) at the benzodiazepine binding site (alpha/gamma interface) or the barbiturate/anesthetic sites; direct agonism at the GABA binding site (beta/alpha interface); antagonism; and pore blocking.